URAC vs ACHC Specialty Pharmacy Accreditation — How They Compare

Last updated: October 2026

URAC and ACHC both accredit specialty pharmacies. Both satisfy PBM network requirements. Both can support limited distribution drug access. But they differ in payer preference, standards focus, cost structure, and strategic value depending on your pharmacy type. This guide gives you a direct side-by-side comparison so you can make the right decision — or understand why dual accreditation may be your best path.

Why This Comparison Matters

Accreditation is not a checkbox — it is a market access strategy. In a large and growing specialty pharmaceutical market, the accreditation you hold can determine which PBM networks you can join, which manufacturers will grant you dispensing contracts, and whether your pharmacy competes as PBM vertical integration continues.

Choosing between URAC and ACHC — or deciding to pursue both — is a strategic decision that affects your revenue for the next 3 years. IHS is a specialized healthcare accreditation consulting firm led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC, and we advise on both URAC and ACHC pathways. Here is how they compare.

URAC vs ACHC Specialty Pharmacy: Side-by-Side Comparison

Both accreditations serve the same fundamental purpose — validating that your specialty pharmacy meets national quality standards — but they approach it differently.

Where URAC May Fit

URAC may fit in three situations: commercial payer contracts that name it, a focus on clinical depth, and institutional settings.

Commercial Payer Preference

Some commercial payers name URAC accreditation for specialty pharmacy network inclusion. If your revenue comes mainly from commercial payer contracts, check which accreditation those contracts name.

Clinical Patient Management Depth

URAC's Patient Management (PM) module requires clinical assessments at therapy initiation, individualized care plans tailored to each patient's comorbidities and medication regimen, psychosocial barrier evaluation, and documented therapeutic interventions.

Hospital and Health System Market

URAC's institutional governance standards and clinical quality measurement framework align naturally with health system quality infrastructure.

North Carolina Session Law 2025-69

North Carolina Session Law 2025-69 (Senate Bill 479, page opened 3 October 2026) defines a specialty pharmacy by accreditation from a nationally recognized accrediting organization and lists four bodies, URAC and ACHC among them. The same law bars a PBM from requiring multiple specialty pharmacy accreditations for participation in a retail pharmacy network that dispenses specialty drugs.

Where ACHC May Fit

ACHC may fit some independent pharmacies and pharmacies that also need DMEPOS accreditation.

Independent Pharmacy Ecosystem

Independent pharmacies can compare the preparation support each accreditor offers before choosing.

DMEPOS and Adjacent Accreditation

If your pharmacy also provides durable medical equipment, prosthetics, orthotics, or supplies, ACHC offers adjacent DMEPOS accreditation that can be coordinated with specialty pharmacy accreditation. URAC does not have a DMEPOS accreditation program.

Operational Focus

ACHC's standards are structured around operational pharmacy practice.

When to Pursue Dual URAC + ACHC Accreditation

Scenarios where pursuing both can make sense:

• Limited distribution drug access: Manufacturers of rare disease, orphan drugs, and high-cost biologics can require more than one accreditation before granting exclusive dispensing contracts. If a drug you want to dispense requires ACHC and you only hold URAC, you are excluded.
• Maximum PBM network flexibility: While all three major PBMs accept both URAC and ACHC, some smaller PBMs or regional networks may prefer one over the other. Dual accreditation lowers the risk of accreditation-based network exclusion.
• Competitive differentiation: some pharmacies hold both accreditations.
• Manufacturer confidence: Drug manufacturers evaluating dispensing partners for limited distribution networks, including for cell and gene therapies, look at the accreditations a pharmacy holds.

Sequencing and Cost Optimization

If pursuing dual accreditation, sequence them by which payer, PBM or manufacturer contract requires a credential first. The PM module's clinical depth builds documentation infrastructure that can be adapted for ACHC requirements. Core policies — grievance processes, adverse event reporting, quality committee structures, and competency assessments — overlap and can be reused with formatting adjustments.

IHS advises on documentation reuse, timeline coordination, and cost optimization across both programs. Pursuing both simultaneously is possible but increases internal resource demands. Organizations with limited compliance staff can pursue one program at a time.

What About The Joint Commission?

The Joint Commission (TJC) accredits pharmacies through its Home Care Accreditation Program. Its pharmacy page lists specialty, infusion, compounding and mail order pharmacy among the services it covers, and says two of the largest pharmacy benefit managers recognize its specialty pharmacy accreditation without naming them (Joint Commission, pharmacy accreditation, page opened October 3, 2026). IHS offers readiness for this program too: see Joint Commission pharmacy accreditation.

IHS Recommendation: Which Accreditation Should You Pursue?

IHS is a specialized healthcare accreditation consulting firm led by Thomas G. Goddard, JD, PhD, former Chief Operating Officer and General Counsel of URAC, and we advise on both URAC and ACHC pathways. Here is our recommendation framework:

• Commercial payer network access is your primary goal: Check which accreditations your target payers' and PBMs' contracts name, and begin with the one they require.
• You are a hospital outpatient pharmacy: Let your payer contracts and your health system's requirements drive the choice.
• You need limited distribution drug access: Check which accreditations the manufacturers' limited distribution contracts name. Some name more than one.
• You are a small independent pharmacy: Evaluate URAC's Small Business program first. If ACHC is required by a specific manufacturer or payer, add it.
• You need DMEPOS accreditation alongside specialty pharmacy: Check whether your DMEPOS and specialty pharmacy payer requirements point to the same accreditor; if they differ, plan for more than one.
• You operate in North Carolina: Session Law 2025-69 lists URAC, ACHC and two other bodies in its specialty pharmacy definition, so the law does not point to one of them.

For a detailed cost comparison, see our URAC Specialty Pharmacy Accreditation Cost Guide. For the full URAC accreditation process breakdown, see our URAC Specialty Pharmacy Accreditation service page.

Ready to Get Started?

Schedule a no-obligation Standard-by-Standard Review with IHS. We will assess your current compliance posture, recommend whether URAC, ACHC, or dual accreditation is the right strategy for your pharmacy, and give you a clear roadmap to accreditation.

Schedule a Free Discovery Session